5.70BMarket Cap
LossP/E TTM
Key Figures
93.068Open
93.570High
1.49MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.40%Turnover Ratio
91.330Prev. Close
88.300Low
102.01MTurnover
LossP/E Static
12.50P/B
0.00%Div Yield TTM
-12.78%ROA
69.20052wk High
1.08Volume Ratio
-77.67MNet Profit
62.15MShares
-1.3188EPS TTM
2.24Beta
-18.16%ROE
23.30052wk Low
5.77%Amplitude
51.59%Gross Margin
5.70BMarket Cap
-2.03Reward/Risk
3.93%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Twist Bioscience Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 12 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 94.33.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Twist Bioscience Corp's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Twist Bioscience Corp Highlights
StrengthsRisks
Twist Bioscience Corp News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Twist Bioscience Corp
TWST
10
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Twist Bioscience Corp Info
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
Ticker SymbolTWST
CompanyTwist Bioscience Corp
CEOLeproust (Emily M)
Websitehttps://www.twistbioscience.com/
Shareholders
FAQs
What is the current price of Twist Bioscience Corp (TWST)?
The current price of Twist Bioscience Corp (TWST) is 91.79.
What is the symbol of Twist Bioscience Corp?
The ticker symbol of Twist Bioscience Corp is TWST.
What is the 52-week high of Twist Bioscience Corp?
The 52-week high of Twist Bioscience Corp is 69.20.
What is the 52-week low of Twist Bioscience Corp?
The 52-week low of Twist Bioscience Corp is 23.30.
What is the market capitalization of Twist Bioscience Corp?
The market capitalization of Twist Bioscience Corp is 5.71B.
Is Twist Bioscience Corp (TWST) currently rated as Buy, Hold, or Sell?
According to analysts, Twist Bioscience Corp (TWST) has an overall rating of STRONG BUY, with a price target of 94.33.
What is the Earnings Per Share (EPS TTM) of Twist Bioscience Corp (TWST)?
The Earnings Per Share (EPS TTM) of Twist Bioscience Corp (TWST) is -1.30.